{
  "DOI": "10.1007/s00439-020-02153-3",
  "ISSN": [
    "0340-6717",
    "1432-1203"
  ],
  "URL": "http://dx.doi.org/10.1007/s00439-020-02153-3",
  "alternative-id": [
    "2153"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "7 January 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "19 March 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "26 March 2020"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "All authors have declared that no competing interests exist."
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "All procedures performed in the study involving human participants were in accordance with Al-Ain Medical Human Research Ethics Committee (AMHREC) according to the national regulations (Approval numbers 10/09 and ERH-2015-3241 15-115) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Samples were collected from the patient after obtaining written informed consents from the parents."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Mohamed",
      "given": "Fedah E.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Al Sorkhy",
      "given": "Mohammad",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ghattas",
      "given": "Mohammad A.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Al-Gazali",
      "given": "Lihadh",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Al-Dirbashi",
      "given": "Osama",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Al-Jasmi",
      "given": "Fatma",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-1306-6618",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Ali",
      "given": "Bassam R.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2020,
        3,
        26
      ]
    ],
    "date-time": "2020-03-26T18:04:20Z",
    "timestamp": 1585245860000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        3,
        26
      ]
    ],
    "date-time": "2021-03-26T00:36:45Z",
    "timestamp": 1616719005000
  },
  "funder": [
    {
      "DOI": "10.13039/501100006014",
      "award": [
        "31R134",
        "31M369"
      ],
      "doi-asserted-by": "publisher",
      "name": "College of Medicine and Health Sciences, United Arab Emirates University"
    },
    {
      "DOI": "10.13039/501100006013",
      "award": [
        "31M289"
      ],
      "doi-asserted-by": "publisher",
      "name": "United Arab Emirates University"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        26
      ]
    ],
    "date-time": "2024-03-26T12:22:51Z",
    "timestamp": 1711455771325
  },
  "is-referenced-by-count": 7,
  "issn-type": [
    {
      "type": "print",
      "value": "0340-6717"
    },
    {
      "type": "electronic",
      "value": "1432-1203"
    }
  ],
  "issue": "5",
  "issued": {
    "date-parts": [
      [
        2020,
        3,
        26
      ]
    ]
  },
  "journal-issue": {
    "issue": "5",
    "published-print": {
      "date-parts": [
        [
          2020,
          5
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            3,
            26
          ]
        ],
        "date-time": "2020-03-26T00:00:00Z",
        "timestamp": 1585180800000
      }
    },
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            3,
            26
          ]
        ],
        "date-time": "2020-03-26T00:00:00Z",
        "timestamp": 1585180800000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-020-02153-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s00439-020-02153-3/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-020-02153-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "657-673",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2020,
        3,
        26
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2020,
        3,
        26
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2020,
        5
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1101/cshperspect.a007526",
      "author": "K Araki",
      "doi-asserted-by": "publisher",
      "journal-title": "Cold Spring Harb Perspect Biol",
      "key": "2153_CR1",
      "unstructured": "Araki K, Nagata K (2011) Protein folding and quality control in the ER. Cold Spring Harb Perspect Biol. https://doi.org/10.1101/cshperspect.a007526",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.ymgme.2008.04.012",
      "author": "N Brunetti-Pierri",
      "doi-asserted-by": "publisher",
      "first-page": "391",
      "journal-title": "Mol Genet Metab",
      "key": "2153_CR2",
      "unstructured": "Brunetti-Pierri N, Scaglia F (2008) GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects. Mol Genet Metab 94:391–396. https://doi.org/10.1016/j.ymgme.2008.04.012",
      "volume": "94",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.bbadis.2011.03.018",
      "author": "A Caciotti",
      "doi-asserted-by": "publisher",
      "first-page": "782",
      "journal-title": "Biochim Biophys Acta",
      "key": "2153_CR3",
      "unstructured": "Caciotti A et al (2011) GM1 gangliosidosis and morquio B disease: an update on genetic alterations and clinical findings. Biochim Biophys Acta 1812:782–790. https://doi.org/10.1016/j.bbadis.2011.03.018",
      "volume": "1812",
      "year": "2011"
    },
    {
      "author": "D Case",
      "key": "2153_CR4",
      "unstructured": "Case D et al (2012) AMBER 12. University of California, San Francisco",
      "volume-title": "AMBER 12",
      "year": "2012"
    },
    {
      "DOI": "10.1110/ps.0240003",
      "author": "MS Celej",
      "doi-asserted-by": "publisher",
      "first-page": "1496",
      "journal-title": "Protein Sci",
      "key": "2153_CR5",
      "unstructured": "Celej MS, Montich GG, Fidelio GD (2003) Protein stability induced by ligand binding correlates with changes in protein flexibility. Protein Sci 12:1496–1506",
      "volume": "12",
      "year": "2003"
    },
    {
      "DOI": "10.4161/pri.28938",
      "author": "L Cortez",
      "doi-asserted-by": "publisher",
      "first-page": "197",
      "journal-title": "Prion",
      "key": "2153_CR6",
      "unstructured": "Cortez L, Sim V (2014) The therapeutic potential of chemical chaperones in protein folding diseases. Prion 8:197–202. https://doi.org/10.4161/pri.28938",
      "volume": "8",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s11011-017-0044-y",
      "author": "F Deodato",
      "doi-asserted-by": "publisher",
      "first-page": "1529",
      "journal-title": "Metab Brain Dis",
      "key": "2153_CR8",
      "unstructured": "Deodato F et al (2017) The treatment of juvenile/adult GM1-gangliosidosis with Miglustat may reverse disease progression. Metab Brain Dis 32:1529–1536. https://doi.org/10.1007/s11011-017-0044-y",
      "volume": "32",
      "year": "2017"
    },
    {
      "DOI": "10.1091/mbc.E16-01-0012",
      "author": "D Dersh",
      "doi-asserted-by": "publisher",
      "first-page": "3813",
      "journal-title": "Mol Biol Cell",
      "key": "2153_CR9",
      "unstructured": "Dersh D, Iwamoto Y, Argon Y (2016) Tay–Sachs disease mutations in HEXA target the alpha chain of hexosaminidase A to endoplasmic reticulum-associated degradation. Mol Biol Cell 27:3813–3827. https://doi.org/10.1091/mbc.E16-01-0012",
      "volume": "27",
      "year": "2016"
    },
    {
      "DOI": "10.1023/B:BOLI.0000031101.12838.c6",
      "author": "RJ Desnick",
      "doi-asserted-by": "publisher",
      "first-page": "385",
      "journal-title": "J Inherit Metab Dis",
      "key": "2153_CR10",
      "unstructured": "Desnick RJ (2004) Enzyme replacement and enhancement therapies for lysosomal diseases. J Inherit Metab Dis 27:385–410. https://doi.org/10.1023/B:BOLI.0000031101.12838.c6",
      "volume": "27",
      "year": "2004"
    },
    {
      "DOI": "10.1002/humu.9279",
      "author": "T Georgiou",
      "doi-asserted-by": "publisher",
      "first-page": "352",
      "journal-title": "Hum Mutat",
      "key": "2153_CR11",
      "unstructured": "Georgiou T et al (2004) Four novel mutations in patients from the Middle East with the infantile form of GM1-gangliosidosis. Hum Mutat 24:352. https://doi.org/10.1002/humu.9279",
      "volume": "24",
      "year": "2004"
    },
    {
      "DOI": "10.1186/s13023-017-0565-9",
      "author": "N Guérard",
      "doi-asserted-by": "publisher",
      "journal-title": "Orphanet J Rare Dis",
      "key": "2153_CR12",
      "unstructured": "Guérard N, Morand O, Dingemanse J (2017) Lucerastat, an iminosugar with potential as substrate reduction therapy for glycolipid storage disorders: safety, tolerability, and pharmacokinetics in healthy subjects. Orphanet J Rare Dis. https://doi.org/10.1186/s13023-017-0565-9",
      "year": "2017"
    },
    {
      "DOI": "10.1002/humu.21516",
      "author": "K Higaki",
      "doi-asserted-by": "publisher",
      "first-page": "843",
      "journal-title": "Hum Mutat",
      "key": "2153_CR13",
      "unstructured": "Higaki K et al (2011) Chemical chaperone therapy: chaperone effect on mutant enzyme and cellular pathophysiology in beta-galactosidase deficiency. Hum Mutat 32:843–852. https://doi.org/10.1002/humu.21516",
      "volume": "32",
      "year": "2011"
    },
    {
      "DOI": "10.4155/fmc.13.123",
      "author": "K Higaki",
      "doi-asserted-by": "publisher",
      "first-page": "1551",
      "journal-title": "Future Med Chem",
      "key": "2153_CR14",
      "unstructured": "Higaki K, Ninomiya H, Suzuki Y, Nanba E (2013) Candidate molecules for chemical chaperone therapy of GM1-gangliosidosis. Future Med Chem 5:1551–1558. https://doi.org/10.4155/fmc.13.123",
      "volume": "5",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.braindev.2006.02.002",
      "author": "H Iwasaki",
      "doi-asserted-by": "publisher",
      "first-page": "482",
      "journal-title": "Brain Dev",
      "key": "2153_CR15",
      "unstructured": "Iwasaki H et al (2006) Fibroblast screening for chaperone therapy in β-galactosidosis. Brain Dev 28:482–486. https://doi.org/10.1016/j.braindev.2006.02.002",
      "volume": "28",
      "year": "2006"
    },
    {
      "DOI": "10.1046/j.1471-4159.2004.02381.x",
      "author": "J Kasperzyk",
      "doi-asserted-by": "publisher",
      "first-page": "645",
      "journal-title": "J Neurochem",
      "key": "2153_CR17",
      "unstructured": "Kasperzyk J, El-Abbadi MM, Hauser EC, D'Azzo A, Platt FM, Seyfried TN (2004) N-Butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis. J Neurochem 89:645–653. https://doi.org/10.1046/j.1471-4159.2004.02381.x",
      "volume": "89",
      "year": "2004"
    },
    {
      "DOI": "10.1038/s41598-017-19053-8",
      "author": "P Kizhakkedath",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Sci Rep",
      "key": "2153_CR18",
      "unstructured": "Kizhakkedath P, John A, Al-Gazali L, Ali BR (2018) Degradation routes of trafficking-defective VLDLR mutants associated with dysequilibrium syndrome. Sci Rep 8:1–12. https://doi.org/10.1038/s41598-017-19053-8",
      "volume": "8",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.phrs.2014.01.005",
      "author": "NJ Leidenheimer",
      "doi-asserted-by": "publisher",
      "first-page": "10",
      "journal-title": "Pharmacol Res",
      "key": "2153_CR19",
      "unstructured": "Leidenheimer NJ, Ryder KG (2014) Pharmacological chaperoning: a primer on mechanism and pharmacology. Pharmacol Res 83:10–19. https://doi.org/10.1016/j.phrs.2014.01.005",
      "volume": "83",
      "year": "2014"
    },
    {
      "DOI": "10.1136/jmedgenet-2019-106005",
      "author": "M Lenders",
      "doi-asserted-by": "publisher",
      "first-page": "548",
      "journal-title": "J Med Genet",
      "key": "2153_CR20",
      "unstructured": "Lenders M et al (2019) Mutation-specific Fabry disease patient-derived cell model to evaluate the amenability to chaperone therapy. J Med Genet 56:548–556. https://doi.org/10.1136/jmedgenet-2019-106005",
      "volume": "56",
      "year": "2019"
    },
    {
      "DOI": "10.1073/pnas.2536657100",
      "author": "J Matsuda",
      "doi-asserted-by": "publisher",
      "first-page": "15912",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "2153_CR21",
      "unstructured": "Matsuda J et al (2003) Chemical chaperone therapy for brain pathology in GM1-gangliosidosis. Proc Natl Acad Sci USA 100:15912–15917. https://doi.org/10.1073/pnas.2536657100",
      "volume": "100",
      "year": "2003"
    },
    {
      "DOI": "10.1007/s40265-019-01090-4",
      "author": "EH McCafferty",
      "doi-asserted-by": "publisher",
      "first-page": "543",
      "journal-title": "Drugs",
      "key": "2153_CR22",
      "unstructured": "McCafferty EH, Scott LJ (2019) Migalastat: a review in fabry disease. Drugs 79:543–554. https://doi.org/10.1007/s40265-019-01090-4",
      "volume": "79",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s00018-016-2386-8",
      "author": "X Meng",
      "doi-asserted-by": "publisher",
      "first-page": "23",
      "journal-title": "Cell Mol Life Sci",
      "key": "2153_CR23",
      "unstructured": "Meng X, Clews J, Kargas V, Wang X, Ford RC (2017) The cystic fibrosis transmembrane conductance regulator (CFTR) and its stability. Cell Mol Life Sci 74:23–38. https://doi.org/10.1007/s00018-016-2386-8",
      "volume": "74",
      "year": "2017"
    },
    {
      "DOI": "10.1167/iovs.14-13885",
      "author": "RM Milhem",
      "doi-asserted-by": "publisher",
      "first-page": "3423",
      "journal-title": "Invest Ophthalmol Vis Sci",
      "key": "2153_CR24",
      "unstructured": "Milhem RM, Ben-Salem S, Al-Gazali L, Ali BR (2014) Identification of the cellular mechanisms that modulate trafficking of frizzled family receptor 4 (FZD4) missense mutants associated with familial exudative vitreoretinopathy. Invest Ophthalmol Vis Sci 55:3423–3431. https://doi.org/10.1167/iovs.14-13885",
      "volume": "55",
      "year": "2014"
    },
    {
      "key": "2153_CR25",
      "unstructured": "MOE (2016) manual version 2016.09, Molecular Operating Environment (MOE), Chemical Computing Group, Montreal, Canada. https://www.chemcomp.com. Accessed 18 Jan 2018"
    },
    {
      "DOI": "10.3389/fphar.2017.00448",
      "author": "FE Mohamed",
      "doi-asserted-by": "publisher",
      "journal-title": "Front Pharmacol",
      "key": "2153_CR26",
      "unstructured": "Mohamed FE, Al-Gazali L, Al-Jasmi F, Ali BR (2017) Pharmaceutical chaperones and proteostasis regulators in the therapy of lysosomal storage disorders: current perspective and future promises. Front Pharmacol. https://doi.org/10.3389/fphar.2017.00448",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.cell.2008.06.037",
      "author": "TW Mu",
      "doi-asserted-by": "publisher",
      "first-page": "769",
      "journal-title": "Cell",
      "key": "2153_CR27",
      "unstructured": "Mu TW, Ong DST, Wang YJ, Balch WE, Yates JR, Segatori L, Kelly JW (2008) Proteostasis regulators and pharmacologic chaperones synergize to correct protein misfolding diseases. Cell 134:769–781. https://doi.org/10.1016/j.cell.2008.06.037",
      "volume": "134",
      "year": "2008"
    },
    {
      "DOI": "10.1093/nar/gkx1095",
      "author": "NCBI Resource Coordinators",
      "doi-asserted-by": "publisher",
      "first-page": "D8",
      "journal-title": "Nucleic Acids Res",
      "key": "2153_CR7",
      "unstructured": "NCBI Resource Coordinators (2018) Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 46:D8–D13. https://doi.org/10.1093/nar/gkx1095",
      "volume": "46",
      "year": "2018"
    },
    {
      "DOI": "10.1074/jbc.M111.293795",
      "author": "U Ohto",
      "doi-asserted-by": "publisher",
      "journal-title": "J Biol Chem",
      "key": "2153_CR28",
      "unstructured": "Ohto U, Usui K, Ochi T, Yuki K, Satow Y, Shimizu T (2012) Crystal structure of human β-galactosidase. J Biol Chem. https://doi.org/10.1074/jbc.M111.293795",
      "year": "2012"
    },
    {
      "DOI": "10.1007/3-540-29717-0_16",
      "author": "E Papp",
      "doi-asserted-by": "publisher",
      "journal-title": "Handb Exp Pharmacol",
      "key": "2153_CR29",
      "unstructured": "Papp E, Csermely P (2006) Chemical chaperones: mechanisms of action and potential use. Handb Exp Pharmacol. https://doi.org/10.1007/3-540-29717-0_16",
      "year": "2006"
    },
    {
      "DOI": "10.1016/S0021-9258(18)47132-3",
      "author": "FM Platt",
      "doi-asserted-by": "crossref",
      "first-page": "27108",
      "journal-title": "J Biol Chem",
      "key": "2153_CR30",
      "unstructured": "Platt FM, Neises GR, Karlsson GB, Dwek RA, Butters TD (1994) N-Butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing. J Biol Chem 269:27108–27114",
      "volume": "269",
      "year": "1994"
    },
    {
      "key": "2153_CR31",
      "unstructured": "RCSB (2015) Protein Data Bank. https://www.rcsb.org/. Accessed 18 Jan 2018"
    },
    {
      "author": "DS Regier",
      "first-page": "663",
      "issue": "Suppl 1",
      "journal-title": "Pediatr Endocrinol Rev",
      "key": "2153_CR32",
      "unstructured": "Regier DS, Proia RL, D'Azzo A, Tifft CJ (2016) The GM1 and GM2 gangliosidoses: natural history and progress toward therapy. Pediatr Endocrinol Rev 13(Suppl 1):663–673",
      "volume": "13",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.ymgme.2012.06.007",
      "author": "BA Rigat",
      "doi-asserted-by": "publisher",
      "first-page": "203",
      "journal-title": "Mol Genet Metab",
      "key": "2153_CR33",
      "unstructured": "Rigat BA et al (2012) Evaluation of N-nonyl-deoxygalactonojirimycin as a pharmacological chaperone for human GM1 gangliosidosis leads to identification of a feline model suitable for testing enzyme enhancement therapy. Mol Genet Metab 107:203–212. https://doi.org/10.1016/j.ymgme.2012.06.007",
      "volume": "107",
      "year": "2012"
    },
    {
      "DOI": "10.1093/hmg/ddi240",
      "author": "I Ron",
      "doi-asserted-by": "publisher",
      "first-page": "2387",
      "journal-title": "Hum Mol Genet",
      "key": "2153_CR34",
      "unstructured": "Ron I, Horowitz M (2005) ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity. Hum Mol Genet 14:2387–2398. https://doi.org/10.1093/hmg/ddi240",
      "volume": "14",
      "year": "2005"
    },
    {
      "DOI": "10.1002/humu.9451",
      "author": "R Santamaria",
      "doi-asserted-by": "publisher",
      "first-page": "1060",
      "journal-title": "Hum Mutat",
      "key": "2153_CR35",
      "unstructured": "Santamaria R, Chabas A, Coll MJ, Miranda CS, Vilageliu L, Grinberg D (2006) Twenty-one novel mutations in the GLB1 gene identified in a large group of GM1-gangliosidosis and Morquio B patients: possible common origin for the prevalent p.R59H mutation among gypsies. Hum Mutat 27:1060. https://doi.org/10.1002/humu.9451",
      "volume": "27",
      "year": "2006"
    },
    {
      "DOI": "10.3762/bjoc.6.21",
      "author": "G Schitter",
      "doi-asserted-by": "publisher",
      "journal-title": "J Org Chem",
      "key": "2153_CR36",
      "unstructured": "Schitter G et al (2010) Synthesis of lipophilic 1-deoxygalactonojirimycin derivatives as d-galactosidase inhibitors Beilstein. J Org Chem. https://doi.org/10.3762/bjoc.6.21",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.biocel.2005.05.008",
      "author": "M Schmitz",
      "doi-asserted-by": "publisher",
      "first-page": "2310",
      "journal-title": "Int J Biochem Cell Biol",
      "key": "2153_CR37",
      "unstructured": "Schmitz M, Alfalah M, Aerts JM, Naim HY, Zimmer KP (2005) Impaired trafficking of mutants of lysosomal glucocerebrosidase in Gaucher's disease. Int J Biochem Cell Biol 37:2310–2320. https://doi.org/10.1016/j.biocel.2005.05.008",
      "volume": "37",
      "year": "2005"
    },
    {
      "DOI": "10.1021/ct700119m",
      "author": "J Shao",
      "doi-asserted-by": "publisher",
      "first-page": "2312",
      "journal-title": "J Chem Theory Comput",
      "key": "2153_CR38",
      "unstructured": "Shao J, Tanner SW, Thompson N, Cheatham TE (2007) Clustering molecular dynamics trajectories: 1. Characterizing the performance of different clustering algorithms. J Chem Theory Comput 3:2312–2334. https://doi.org/10.1021/ct700119m",
      "volume": "3",
      "year": "2007"
    },
    {
      "DOI": "10.1007/s00439-013-1358-4",
      "author": "PD Stenson",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Hum Genet",
      "key": "2153_CR39",
      "unstructured": "Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN (2014) The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet 133:1–9. https://doi.org/10.1007/s00439-013-1358-4",
      "volume": "133",
      "year": "2014"
    },
    {
      "DOI": "10.2183/pjab.90.145",
      "author": "Y Suzuki",
      "doi-asserted-by": "publisher",
      "first-page": "145",
      "journal-title": "Proc Jpn Acad Ser B Phys Biol Sci",
      "key": "2153_CR40",
      "unstructured": "Suzuki Y (2014) Emerging novel concept of chaperone therapies for protein misfolding diseases. Proc Jpn Acad Ser B Phys Biol Sci 90:145–162",
      "volume": "90",
      "year": "2014"
    },
    {
      "DOI": "10.1063/1.464397",
      "author": "D Tom",
      "doi-asserted-by": "publisher",
      "first-page": "10089",
      "journal-title": "J Chem Phys",
      "key": "2153_CR41",
      "unstructured": "Tom D, Darrin Y, Lee P (1993) Particle mesh Ewald: an N log(N) method for Ewald sums in large systems. J Chem Phys 98:10089–10092. https://doi.org/10.1063/1.464397",
      "volume": "98",
      "year": "1993"
    },
    {
      "DOI": "10.1016/s0387-7604(01)00216-9",
      "author": "L Tominaga",
      "doi-asserted-by": "publisher",
      "first-page": "284",
      "journal-title": "Brain Dev",
      "key": "2153_CR42",
      "unstructured": "Tominaga L et al (2001) Galactonojirimycin derivatives restore mutant human beta-galactosidase activities expressed in fibroblasts from enzyme-deficient knockout mouse. Brain Dev 23:284–287. https://doi.org/10.1016/s0387-7604(01)00216-9",
      "volume": "23",
      "year": "2001"
    },
    {
      "DOI": "10.1016/j.ymgme.2017.04.011",
      "author": "JR Utz",
      "doi-asserted-by": "publisher",
      "first-page": "170",
      "journal-title": "Mol Genet Metab",
      "key": "2153_CR16",
      "unstructured": "Utz JR, Kim S, King K, Ziegler R, Schema L, Redtree ES, Whitley CB (2017) Infantile gangliosidoses: mapping a timeline of clinical changes. Mol Genet Metab 121:170–179. https://doi.org/10.1016/j.ymgme.2017.04.011",
      "volume": "121",
      "year": "2017"
    },
    {
      "DOI": "10.1074/jbc.275.14.10035",
      "author": "A van der Spoel",
      "doi-asserted-by": "publisher",
      "first-page": "10035",
      "journal-title": "J Biol Chem",
      "key": "2153_CR43",
      "unstructured": "van der Spoel A, Bonten E, d'Azzo A (2000) Processing of lysosomal beta-galactosidase. The C-terminal precursor fragment is an essential domain of the mature enzyme. J Biol Chem 275:10035–10040. https://doi.org/10.1074/jbc.275.14.10035",
      "volume": "275",
      "year": "2000"
    },
    {
      "DOI": "10.1186/1471-2105-11-548",
      "author": "H Venselaar",
      "doi-asserted-by": "publisher",
      "first-page": "548",
      "journal-title": "BMC Bioinform",
      "key": "2153_CR44",
      "unstructured": "Venselaar H, Te Beek TA, Kuipers RK, Hekkelman ML, Vriend G (2010) Protein structure analysis of mutations causing inheritable diseases. An e-science approach with life scientist friendly interfaces. BMC Bioinform 11:548. https://doi.org/10.1186/1471-2105-11-548",
      "volume": "11",
      "year": "2010"
    },
    {
      "DOI": "10.1186/2193-1801-2-402",
      "author": "A Warmerdam",
      "doi-asserted-by": "publisher",
      "journal-title": "Springerplus",
      "key": "2153_CR45",
      "unstructured": "Warmerdam A, Boom RM, Janssen AE (2013) β-galactosidase stability at high substrate concentrations. Springerplus. https://doi.org/10.1186/2193-1801-2-402",
      "year": "2013"
    },
    {
      "DOI": "10.1093/hmg/ddy248",
      "author": "RWD Welford",
      "doi-asserted-by": "publisher",
      "first-page": "3392",
      "journal-title": "Hum Mol Genet",
      "key": "2153_CR46",
      "unstructured": "Welford RWD et al (2018) Glucosylceramide synthase inhibition with lucerastat lowers globotriaosylceramide and lysosome staining in cultured fibroblasts from Fabry patients with different mutation types. Hum Mol Genet 27:3392–3403. https://doi.org/10.1093/hmg/ddy248",
      "volume": "27",
      "year": "2018"
    },
    {
      "DOI": "10.1042/bj3480621",
      "author": "S Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "621",
      "issue": "Pt 3",
      "journal-title": "Biochem J",
      "key": "2153_CR47",
      "unstructured": "Zhang S, Bagshaw R, Hilson W, Oho Y, Hinek A, Clarke JT, Callahan JW (2000) Characterization of beta-galactosidase mutations Asp332--%3eAsn and Arg148--%3eSer, and a polymorphism, Ser532--%3eGly, in a case of GM1 gangliosidosis. Biochem J 348(Pt 3):621–632",
      "volume": "348",
      "year": "2000"
    },
    {
      "DOI": "10.1155/2012/805827",
      "author": "Z Zhang",
      "doi-asserted-by": "publisher",
      "journal-title": "Comput Math Methods Med",
      "key": "2153_CR48",
      "unstructured": "Zhang Z, Miteva MA, Wang L, Alexov E (2012) Analyzing effects of naturally occurring missense mutations. Comput Math Methods Med. https://doi.org/10.1155/2012/805827",
      "year": "2012"
    }
  ],
  "reference-count": 48,
  "references-count": 48,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s00439-020-02153-3"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "The pharmacological chaperone N-n-butyl-deoxygalactonojirimycin enhances β-galactosidase processing and activity in fibroblasts of a patient with infantile GM1-gangliosidosis"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "139"
}